Biomarin Pharmaceutical (BMRN) EBT Margin Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.52 Bn |
8.29 Bn |
571.21 Mn |
891.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
891.00 |
| Dec 31, 2025 |
16.00 |
| Sep 30, 2025 |
-301.00 |
| Jun 30, 2025 |
2,956.00 |
| Mar 31, 2025 |
611.00 |
| Dec 31, 2024 |
3,750.00 |
| Sep 30, 2024 |
2,932.00 |
| Jun 30, 2024 |
1,574.00 |
| Mar 31, 2024 |
1,149.00 |
| Dec 31, 2023 |
1,336.00 |
| Sep 30, 2023 |
2,001.00 |
| Jun 30, 2023 |
2,174.00 |
| Mar 31, 2023 |
-1,067.00 |
| Dec 31, 2022 |
-111.00 |
| Sep 30, 2022 |
-251.00 |
| Jun 30, 2022 |
1,733.00 |
| Mar 31, 2022 |
3,905.00 |
| Dec 31, 2021 |
-254.00 |
| Sep 30, 2021 |
-634.00 |
| Jun 30, 2021 |
1,065.00 |
